Filters
New
Hikma launches Methylene Blue Injection, USP in the US
Press Release, Product
25 June 2025
New
Meet Ashanti Finley, Specialist in the People Function team at Berkeley Heights, US. Hear what she has to say about life...
Story, Life at Hikma
06 June 2025
New
Inspiring women of Hikma - Meet Stephanie Haas, Senior Director, Head of Hikma Rx Procurement
Story, Leadership
05 June 2025
Hikma launches Triamcinolone Acetonide Injectable Suspension, USP, in the US
Press Release, Product
05 June 2025
Fitch upgrades Hikma Pharmaceuticals PLC’s long-term issuer default rating to ‘BBB’, outlook stable
Press Release, Corporate
29 May 2025
Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosim...
Press Release, Product
27 May 2025
New
Hikma announces strong medium-term Group guidance ahead of its US site visit
Press Release, Corporate
15 May 2025
New
Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits
Press Release, Corporate
08 May 2025
S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable
Press Release, Corporate
08 May 2025
Hikma reiterates full year guidance following good start to the year
Press Release, Corporate
24 April 2025
Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France
Insight, Life at Hikma
17 April 2025
Hikma acquires Novugen’s FDA-approved ANDA for trametinib
Press Release, Product
17 April 2025
Hikma signs exclusive licensing agreement with pharma& to bring innovative oncology treatment to MENA
Press Release, Business Development
09 April 2025
New
Hikma launches Cisatracurium Besylate Injection, USP in the US
Press Release, Product
25 March 2025
New
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Press Release, Product
20 March 2025
You have viewed 15 of 495 results